Citi Ventures

Headquartered in San Francisco with offices globally, Citi Ventures explores, incubates, and invests in innovative ideas across fintech, data analytics, commerce, security, marketing, property tech, distributed ledger technology, and digital assets. It collaborates with Citi colleagues, clients, and the broader innovation community to drive discovery of new value.

Omar Amireh

Cheif Executive Officer / Citi Country Officer

Avi Arnon

Vice President

Krishna Balachanader

Managing Director

Thompson Barro

Vice President

Karine Ben-Simhon

VP Intelligence Partnerships and Innovation

Matt Carbonara

Managing Director

Alex Chen

Vice President

Kateryna Chupryna

Director

Xiaolei Cong

Vice President

Fernando Dammert

COO of Financial Institutions Sales and Solutions

Lauren Gross

Investment Banking Analyst

Ignacio Gutiérrez-Orrantia

CEO, Citibank Europe

Lizzie Guynn

Vice President

Charles Howe

Investor

Darren Jarvis

ICG Chief Administrative Officer

Cagla Kaymaz

Senior Vice President

Lucas Kirshenbaum

Assistant Vice President

Manish Kohli

Global Head of Payments and Receivables

Ian Lee

Director, Innovation Network

Everett Leonidas

Director

Robert Li

Vice President, Citi Ventures

Paul Marshall

Director, Global Finance Product Transformation

Duncan McCredie

Global Head of Strategy - Citi Commercial Bank

Jeff Meyers

Investor

Blaze O'Byrne

Vice President

Margo Pilic

Chief of Staff to the CEO

Arvind Purushotham

Managing Director

Vibhor Rastogi

Managing Director

Meredith Shields

Managing Director

Ornit Shinar

Managing Director

Lee Smallwood

Head of Rates Digital Assets

Clark Smith

CISO Head of Engineering and Architecture Practice, Managing Director

Cece Stewart

President

Kate Sullivan

COO

Alyssa Tam

Judge and Mentor - Citi Mobile Challenge

Avery Tiras

Equity Research Senior Associate

Luis Valdich

Managing Director

Jelena Zec

Director

Past deals in Serbia

Swixx Biopharma

Debt Financing in 2021
Swixx Biopharma is a specialized company that provides comprehensive representation for biopharma, over-the-counter (OTC), and medical device firms in Central and Eastern Europe (CEE). Founded in 2014 and based in Baar, Switzerland, Swixx Biopharma operates fully-owned affiliates across various CEE countries, including Albania, Bulgaria, Poland, and Romania, among others. The company aims to fill the gap left by multinational corporations that choose not to enter or exit specific markets or therapeutic areas. With a focus on rare diseases, oncology-hematology, specialty treatments, and self-medication, Swixx Biopharma leverages its research expertise to deliver effective health solutions tailored to the needs of the region.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.